Latest Insider Transactions at Optimize Rx Corp (OPRX)

OPRX Quotes by TradingView

This section provides a real-time view of insider transactions for Optimize Rx Corp (OPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of OptimizeRx Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of OptimizeRx Corp's insiders and make more informed investment decisions.

Insider Transaction List

Date Insider Transaction Ownership Type Shares Traded Value / Price
Sep 02 2021
Miriam J Paramore PRESIDENT AND CSO
BUY
Exercise of conversion of derivative security
Direct
15,000 +14.34%
$105,000 $7.51 P/Share
Aug 31 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
4,000 -7.3%
$264,000 $66.62 P/Share
Aug 24 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
4,000 -6.8%
$244,000 $61.5 P/Share
Aug 20 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
5,000 -7.84%
$290,000 $58.45 P/Share
Aug 17 2021
Stephen L Silvestro Chief Commercial Officer
SELL
Open market or private sale
Direct
13,242 -100.0%
$768,036 $58.41 P/Share
Aug 17 2021
Stephen L Silvestro Chief Commercial Officer
BUY
Exercise of conversion of derivative security
Direct
13,242 +50.0%
$92,694 $7.51 P/Share
Aug 17 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
4,000 -5.9%
$232,000 $58.46 P/Share
Aug 16 2021
William J Febbo CEO
SELL
Open market or private sale
Direct
16,666 -2.97%
$999,960 $60.46 P/Share
Aug 13 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
5,000 -6.87%
$315,000 $63.27 P/Share
Aug 10 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
2,000 -2.67%
$128,000 $64.5 P/Share
Aug 09 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
10,000 -13.37%
$640,000 $64.31 P/Share
Aug 03 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
2,000 -2.6%
$108,000 $54.93 P/Share
Aug 02 2021
Miriam J Paramore PRESIDENT AND CSO
SELL
Open market or private sale
Direct
15,000 -16.74%
$825,000 $55.76 P/Share
Aug 02 2021
Miriam J Paramore PRESIDENT AND CSO
BUY
Exercise of conversion of derivative security
Direct
15,000 +14.34%
$105,000 $7.51 P/Share
Jul 27 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
3,000 -3.76%
$156,000 $52.58 P/Share
Jul 20 2021
Stephen L Silvestro Chief Commercial Officer
SELL
Open market or private sale
Direct
13,242 -100.0%
$662,100 $50.34 P/Share
Jul 20 2021
Stephen L Silvestro Chief Commercial Officer
BUY
Exercise of conversion of derivative security
Direct
13,242 +50.0%
$92,694 $7.51 P/Share
Jul 20 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
3,000 -3.62%
$150,000 $50.9 P/Share
Jul 15 2021
Miriam J Paramore PRESIDENT AND CSO
SELL
Exercise of conversion of derivative security
Direct
67,195 -47.39%
$201,585 $3.15 P/Share
Jul 08 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
BUY
Exercise of conversion of derivative security
Direct
13,435 +13.96%
$26,870 $2.46 P/Share
Jul 08 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
13,435 -16.23%
$752,360 $56.05 P/Share
Jul 02 2021
Miriam J Paramore PRESIDENT AND CSO
SELL
Open market or private sale
Direct
15,000 -66.93%
$855,000 $57.81 P/Share
Jul 02 2021
Miriam J Paramore PRESIDENT AND CSO
BUY
Exercise of conversion of derivative security
Direct
15,000 +40.09%
$45,000 $3.15 P/Share
Jun 30 2021
Gus D Halas Director
BUY
Grant, award, or other acquisition
Direct
407 +0.62%
-
Jun 30 2021
James Paul Lang Director
BUY
Grant, award, or other acquisition
Direct
407 +1.23%
-
Jun 30 2021
Patrick D Spangler Director
BUY
Grant, award, or other acquisition
Direct
407 +1.79%
-
Jun 30 2021
Ellen O'Connor Vos Director
BUY
Grant, award, or other acquisition
Direct
407 +1.22%
-
Jun 30 2021
Gregory D Wasson Director
BUY
Grant, award, or other acquisition
Direct
407 +2.22%
-
Jun 28 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
3,421 -3.97%
$215,523 $63.0 P/Share
Jun 24 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
4,000 -4.43%
$240,000 $60.0 P/Share
Jun 17 2021
Stephen L Silvestro Chief Commercial Officer
SELL
Open market or private sale
Direct
13,242 -100.0%
$701,826 $53.44 P/Share
Jun 17 2021
Stephen L Silvestro Chief Commercial Officer
BUY
Exercise of conversion of derivative security
Direct
13,242 +50.0%
$92,694 $7.51 P/Share
Jun 07 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
BUY
Exercise of conversion of derivative security
Direct
14,500 +13.85%
$29,000 $2.46 P/Share
Jun 07 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
14,500 -16.07%
$754,000 $52.62 P/Share
Jun 04 2021
Miriam J Paramore PRESIDENT AND CSO
BUY
Open market or private sale
Direct
13,333 +64.27%
$666,650 $50.85 P/Share
Jun 04 2021
Miriam J Paramore PRESIDENT AND CSO
SELL
Exercise of conversion of derivative security
Direct
13,333 -39.12%
$39,999 $3.15 P/Share
Jun 04 2021
Miriam J Paramore PRESIDENT AND CSO
SELL
Open market or private sale
Direct
1,667 -18.36%
$85,017 $51.3 P/Share
May 18 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
BUY
Exercise of conversion of derivative security
Direct
14,500 +13.85%
$29,000 $2.46 P/Share
May 18 2021
Douglas P Baker CHIEF FINANCIAL OFFICER
SELL
Open market or private sale
Direct
14,500 -16.07%
$652,500 $45.85 P/Share
May 17 2021
Stephen L Silvestro Chief Commercial Officer
BUY
Exercise of conversion of derivative security
Direct
13,242 +50.0%
$92,694 $7.51 P/Share
May 17 2021
Stephen L Silvestro Chief Commercial Officer
SELL
Open market or private sale
Direct
13,242 -100.0%
$556,164 $42.72 P/Share
May 17 2021
Miriam J Paramore PRESIDENT AND CSO
SELL
Open market or private sale
Direct
15,000 -62.29%
$630,000 $42.95 P/Share
Mar 31 2021
Gus D Halas Director
BUY
Grant, award, or other acquisition
Direct
539 +0.83%
-
Mar 31 2021
James Paul Lang Director
BUY
Grant, award, or other acquisition
Direct
539 +1.64%
-
Mar 31 2021
Patrick D Spangler Director
BUY
Grant, award, or other acquisition
Direct
539 +2.4%
-
Mar 31 2021
Ellen O'Connor Vos Director
BUY
Grant, award, or other acquisition
Direct
539 +1.63%
-
Mar 31 2021
Gregory D Wasson Director
BUY
Grant, award, or other acquisition
Direct
539 +2.98%
-
Mar 25 2021
William J Febbo CEO
SELL
Payment of exercise price or tax liability
Direct
26,710 -4.54%
$1,255,370 $47.44 P/Share
Mar 25 2021
William J Febbo CEO
BUY
Exercise of conversion of derivative security
Direct
394,739 +40.17%
$1,184,217 $3.21 P/Share

Track Institutional and Insider Activities on OPRX

Follow OptimizeRx Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if
Any

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to OptimizeRx Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OPRX